Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up

References

• MRugge, PCorrea, MFDixon, RFiocca, THattori, JLechago, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249–59.
   PubMed Web of Science ®Google Scholar
• ELahner, BAnnibale. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 2009;15:5121–8.
   PubMed Web of Science ®Google Scholar
• PCorrea. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735–40.
   PubMed Web of Science ®Google Scholar
• MMHaber. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol Clin North Am 2002;31:395–419.
   PubMed Web of Science ®Google Scholar
• JLWhiting, ASigurdsson, DCRowlands, MTHallissey, JWFielding. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378–81.
   PubMed Web of Science ®Google Scholar
• MDinis-Ribeiro, CLopes, Ada Costa-Pereira, MGuilherme, JBarbosa, HLomba-Viana, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol 2004;57:177–82.
   PubMed Web of Science ®Google Scholar
• LVannella, ELahner, JOsborn, CBordi, MMiglione, GDelle Fave, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010;31:1042–50.
   PubMed Web of Science ®Google Scholar
• LVannella, ELahner, JOsborn, BAnnibale. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013;37:375–82.
   PubMed Web of Science ®Google Scholar
• DMParkin, FBray, JFerlay, PPisani. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   Google Scholar
• NUemura, SOkamoto, SYamamoto, NMatsumura, SYamaguchi, MYamakido, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–9.
   PubMed Web of Science ®Google Scholar
• AMeining, AMorgner, SMiehlke, EBayerdörffer, MStolte. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001;15:983–98.
   PubMed Web of Science ®Google Scholar
• SMiehlke, AHackelsberger, AMeining, RHatz, NLehn, PMalfertheiner, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998;78:263–6.
   PubMed Web of Science ®Google Scholar
• AJWaring, IMDrake, CJSchorah, KLWhite, DALynch, ATAxon, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996;38:171–6.
   PubMed Web of Science ®Google Scholar
• BAnnibale, GCapurso, ELahner, SPassi, RRicci, FMaggio, et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 2003;52:496–501.
   PubMed Web of Science ®Google Scholar
• GDelle Fave, DJKwekkeboom, EVan Cutsem, GRindi, BKos-Kudla, UKnigge, et al. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012;95:74–87.
   PubMed Web of Science ®Google Scholar
• FTBosman, FCarneiro, RHHruban, NDTheise. World Health Organization. WHO classification of tumours of the digestive system. Lyon, France: IARC press; 2010:pp.417.
   Google Scholar
• CBordi, TD’Adda, CAzzoni, GFerraro. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 1998;71:273–84.
   PubMed Web of Science ®Google Scholar
• GJDockray, AVarro, RDimaline, TWang. The gastrins: their production and biological activities. Annu Rev Physiol 2001;63:119–39.
   PubMed Web of Science ®Google Scholar
• CBordi, TD’Adda, CAzzoni, FPPilato, PCaruana. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995;19:S8–19.
   PubMed Web of Science ®Google Scholar
• BAnnibale, CAzzoni, VDCorleto, Edi Giulio, PCaruana, GD’Ambra, et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol 2001;13:1449–56.
   PubMed Web of Science ®Google Scholar
• AKokkola, SMSjöblom, RHaapiainen, PSipponen, PPuolakkainen, HJärvinen. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998;33:88–92.
   PubMed Web of Science ®Google Scholar
• SMSjöblom, PSipponen, MMiettinen, SLKaronen, HJJrvinen. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy 1988;20:52–6.
   PubMed Web of Science ®Google Scholar
• LVannella, ASbrozzi-Vanni, ELahner, CBordi, EPilozzi, VDCorleto, et al. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment Pharmacol Ther 2011;33:1361–9.
   PubMed Web of Science ®Google Scholar
• SMSjöblom, PSipponen, HJärvinen. Gastroscopic follow up of pernicious anaemia patients. Gut 1993;34:28–32.
   PubMed Web of Science ®Google Scholar
• UArmbrecht, RWStockbrügger, JRode, GGMenon, PBCotton. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut 1990;31:1105–9.
   PubMed Web of Science ®Google Scholar
• RWStockbrügger, GGMenon, JOBeilby, RRMason, PBCotton. Gastroscopic screening in 80 patients with pernicious anaemia. Gut 1983;24:1141–7.
   PubMed Web of Science ®Google Scholar
• MDinis-Ribeiro, MAreia, ACde Vries, RMarcos-Pinto, MMonteiro-Soares, CPereira, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPE). Endoscopy 2012;44:74–94.
   PubMed Web of Science ®Google Scholar
• ELahner, PCaruana, GD’Ambra, GFerraro, EDi Giulio, GDelle Fave, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc 2001;53:443–8.
   PubMed Web of Science ®Google Scholar
• EMerola, ASbrozzi Vanni, FPanzuto, GD’Ambra, EDi Giulio, EPilozzi, et al. Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology 2011;95:207–13.
   PubMed Web of Science ®Google Scholar
• ACde Vries, JHaringsma, EJKuipers. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007;12:1–15.
   PubMed Web of Science ®Google Scholar
• BAnnibale, MMarignani, CAzzoni, GD’Ambra, PCaruana, TD’Adda, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997;2:57–64.
   PubMed Web of Science ®Google Scholar
• MFDixon, RMGenta, JHYardley, PCorrea. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–81.
   PubMed Web of Science ®Google Scholar
• ELahner, GLNorman, CSeveri, SEncabo, ZShums, LVannella, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 2009;104:2071–9.
   PubMed Web of Science ®Google Scholar
• MRugge, PCorrea, MFDixon, THattori, GLeandro, KLewin, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000;24:167–76.
   PubMed Web of Science ®Google Scholar
• RHStanley, AALauri. Pathology and genetics of tumours of digestive system. Lyon, France: IARC Press; 2002. pp 46–8.
   Google Scholar
• IMModlin, KDLye, MKidd. Carcinoid tumors of the stomach. Surg Oncol 2003;12:153–72.
   PubMed Web of Science ®Google Scholar
• ELahner, CBordi, EDi Giulio, PCaruana, GD’Ambra, MMilione, et al. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther 2002;16:507–14.
   PubMed Web of Science ®Google Scholar
• GLOBOCAN 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International agency for research on cancer, world health organization. Available from http://globocan.iarc.fr/old/factsheet.asp. Last accessed 1 April 2014.
   Google Scholar
• IMModlin, SFMoss, KOberg, RPadbury, RJHicks, BIGustafsson, et al. Gastrointestinal neuroendocrine (carcinoid) tumors: Current diagnosis and management. Med J Aust 2012;193:46–52.
   Web of Science ®Google Scholar
• LMarques-Silva, MAreia, LElvas, MDinis-Ribeiro. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014;26:378–87.
   PubMed Web of Science ®Google Scholar
• MRugge, LGCapelle, RCappellesso, DNitti, EJKuipers. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 2013;27:205–23.
   PubMed Web of Science ®Google Scholar
• MMWalker, NJTalley. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract – beyond the era of Helicobacter pylori. Aliment Pharmacol Ther 2014;10.1111/apt.12666.
   Web of Science ®Google Scholar
• HLWaldum, OHauso, RFossmark. The regulation of gastric acid secretion – clinical perspectives. Acta Physiol (Oxf) 2013; Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• RFossmark, GOvigstad, HLWaldum. Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol 2008;14:1646–51.
   PubMed Web of Science ®Google Scholar
• DForman, VJBurley. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006;20:633–49.
   PubMed Web of Science ®Google Scholar